Company: NE-WTA
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0001895262-25-000016
Chunk: 16

Company: Noble Corp plc
Filing Date: 2025-10-28
Form: 10-Q
Item: Item 1
Chunk 16
---
 the requirement to disclose the nature and estimate of the range of the reasonably possible change in unrecognized tax benefits for the 12 months after the balance sheet date. The provisions of ASU No. 2023-09 are effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company expects this pronouncement will require changes to our tax reporting processes due to the expanded income tax disclosure requirements, but we do not anticipate the pronouncement will change total reported tax expense, tax assets, or tax liabilities.

10

NOBLE CORPORATION plc AND SUBSIDIARIESNOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Unless otherwise indicated, dollar and share amounts in tables are in thousands, except per share data)

Note 4 — Income (Loss) Per ShareThe following table presents the computation of basic and diluted income (loss) per share:Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Numerator:Net income (loss)$(21,095)$61,216 $130,080 $351,705 Denominator:Weighted average shares outstanding – basic158,834 149,727 158,879 144,863 Dilutive effect of share-based awards— 1,877 1,999 1,877 Dilutive effect of warrants— 1,334 835 1,502 Weighted average shares outstanding – diluted158,834 152,938 161,713 148,242 Per share data:BasicNet income (loss)$(0.13)$0.41 $0.82 $2.43 DilutedNet income (loss)$(0.13)$0.40 $0.80 $2.37 Only those items having a dilutive impact on our basic income (loss) per share are included in diluted income (loss) per share. The following table displays the share-based instruments that have been excluded from diluted income (loss) per share since the effect would have been anti-dilutive:Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Share-based awards1,999 — — — Warrants (1)3,676 10,242 2,773 10,242 (1)Represents the total number of warrants outstanding which did not have a dilutive effect. In periods